BPC-157
Titan names BPC-157 in its injectable-peptide catalog; current regulatory and dispensing details should be confirmed directly.
Provider source ↗
Tampa, FL · Telehealth available
Provider overview
Titan Medical Center publishes an in-person Tampa clinic and telemedicine access described as nationwide, but this directory records Florida only because no state-by-state coverage table was found. Its current injectable-peptide page names BPC-157, CJC-1295 with ipamorelin, GHK-Cu, thymosin alpha-1, TB-500, and tesamorelin. Those are provider-advertised offerings, not independent findings about approval, legal availability, pharmacy sourcing, formulation, safety, effectiveness, or suitability.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
Titan names BPC-157 in its injectable-peptide catalog; current regulatory and dispensing details should be confirmed directly.
Provider source ↗This combination appears in the clinic's public peptide menu without editorial endorsement.
Provider source ↗GHK-Cu is listed in the provider's current injectable-peptide catalog.
Provider source ↗Both names appear in the provider's peptide catalog; status, formulation, and availability require confirmation.
Provider source ↗Tesamorelin is named as an injectable option after clinician evaluation.
Provider source ↗The clinic advertises laboratory-informed testosterone and women's bioidentical hormone services.
Provider source ↗The provider lists clinician-directed weight-management programs among its current services.
Provider source ↗Laboratory testing is published as part of hormone, peptide, and wellness pathways.
Provider source ↗The clinic lists IV therapy plus vitamin and amino-acid injections in its service catalog.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity care model and service scope · Checked Aug 3, 2026
Supports: address phone email and telemedicine claim · Checked Aug 3, 2026
Supports: specific injectable peptide catalog · Checked Aug 3, 2026